NCT06349928 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Air M
Health care seeking behavior and perceptions of the medical profession among pre- and post-retirement age Dutch dancers. J Dance Med Sci. 2009;13(2):42-50.
McEwen K, Young K
Ballet and pain: reflections on a risk-dance culture. Qualitative Research in Sport, Exercise and Health (2011) 3:2, 152-173
Vassallo AJ, Pappas E, Stamatakis E, Hiller CE
Injury Fear, Stigma, and Reporting in Professional Dancers. Saf Health Work. 2019 Sep;10(3):260-264. doi: 10.1016/j.shaw.2019.03.001. Epub 2019 Mar 23.

"The Show Must go on". The Experience of Injuries Among Dancers: Fears, Thoughts, and Beliefs. A Qualitative Study

Clinical trial NCT06349928 - References